Sunmax Biotechnology Revenue

Sunmax Biotechnology had revenue of 460.13M TWD in the quarter ending June 30, 2025, with 1.42% growth. This brings the company's revenue in the last twelve months to 1.95B, up 10.87% year-over-year. In the year 2024, Sunmax Biotechnology had annual revenue of 1.82B with 7.64% growth.

Revenue (ttm)

1.95B

Revenue Growth

+10.87%

P/S Ratio

11.43

Revenue / Employee

n/a

Employees

n/a

Market Cap

22.30B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	1.82B	129.03M	7.64%
Dec 31, 2023	1.69B	288.91M	20.64%
Dec 31, 2022	1.40B	364.42M	35.19%
Dec 31, 2021	1.04B	179.81M	21.01%
Dec 31, 2020	855.85M	261.71M	44.05%
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro
Dec 31, 2016	Pro	Pro	Pro
Dec 31, 2015	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Caliway Biopharmaceuticals	44.83M
PharmaEssentia	12.63B
Bora Pharmaceuticals Co., LTD.	21.32B
Lotus Pharmaceutical	19.12B
Oneness Biotech	112.57M
Lumosa Therapeutics	37.25M
Polaris Group	87.67M
Center Laboratories	1.63B

Revenue Rankings